[Federal Register Volume 86, Number 235 (Friday, December 10, 2021)]
[Notices]
[Page 70439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26761]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-80-2021]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts, Notification 
of Proposed Production Activity, Wyeth Pharmaceuticals, LLC (mRNA Bulk 
Drug Substance), Andover, Massachusetts

    Wyeth Pharmaceuticals, LLC (Wyeth) submitted a notification of 
proposed production activity to the FTZ Board for its facility in 
Andover, Massachusetts within Subzone 27R. The notification conforming 
to the requirements of the Board's regulations (15 CFR 400.22) was 
received on December 3, 2021.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status materials/components described 
in the submitted notification (summarized below) and subsequently 
authorized by the Board. The benefits that may stem from conducting 
production activity under FTZ procedures are explained in the 
background section of the Board's website--accessible via 
www.trade.gov/ftz. The proposed materials/components would be added to 
the production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed foreign-status materials and components include 
Pyrophosphatase Inorganic Animal Origin Free (AOF), Rnase-Free Dnase I, 
Rnase Inhibitor, and Uridine-5'-triphosphate (UTP) (duty rate ranges 
from duty-free to 6.5%). The request indicates that certain materials/
components are subject to duties under Section 301 of the Trade Act of 
1974 (section 301), depending on the country of origin. The applicable 
Section 301 decisions require subject merchandise to be admitted to 
FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is January 19, 
2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: December 6, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021-26761 Filed 12-9-21; 8:45 am]
BILLING CODE 3510-DS-P